Dental Care Clinics in Williston Park, NY Accepting Medicare
3 Dental Care Clinics found. Showing 1 - 3
 Hillside Dental Care Pllc Dentist Medicare: Not Enrolled in Medicare Practice Location: 215 Hillside Ave, Williston Park, NY 11596 Phone: 516-741-2800 |
Drs. Seltzer And Rein Clinic/Center - Dental Medicare: Medicare Enrolled Practice Location: 101 Hillside Ave, Suite A, Williston Park, NY 11596 Phone: 516-741-6202 |
National Dental Pllc Dentist - Endodontics Medicare: Not Enrolled in Medicare Practice Location: 215 Hillside Ave, Williston Park, NY 11596 Phone: 516-741-2800 |
News Archive
New discovery could open door to potential treatment for West Nile virus and Dengue virus infections
A new discovery from the University of Alberta's Faculty of Medicine & Dentistry could open the door to one day treat or prevent diseases caused by West Nile virus and Dengue virus infections.
Alarmins are the 'gold' in breast milk
Breast milk strengthens a child's immune system, supporting the intestinal flora. These facts are common knowledge.
Contraceptive use likely prevents more than 272,000 maternal deaths from childbirth each year
Contraceptive use likely prevents more than 272,000 maternal deaths from childbirth each year, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health. Researchers further estimate that satisfying the global unmet need for contraception could reduce maternal deaths an additional 30 percent. Their findings were published July 10 by The Lancet as part of a series of articles on family planning.
Researchers find that protein serves as on-off switch for "beigeing" of fat
Scientists this week reported that a molecular pathway called mTORC1 controls the conversion of unhealthy white fat into beige fat, an appealing target for increasing energy expenditure and reducing obesity.
IBI initiates Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090
Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic pharmaceuticals announced today that it has initiated its Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090 in patients undergoing cataract surgery.
› Verified 7 days ago